Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

(2020) Alexandre Alanio et al.   Lancet Respiratory Medicine

Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study

(2020) Michele Bartoletti et al.   CLINICAL INFECTIOUS DISEASES

CT lung lesions as predictors of early death or ICU admission in COVID-19 patients

(2020) Yvon Ruch et al.   CLINICAL MICROBIOLOGY AND INFECTION

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

(2020) Paul E. Verweij et al.   INTENSIVE CARE MEDICINE

Azithromycin for severe COVID-19

(2020) Catherine E Oldenburg et al.   LANCET

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response

(2020) Thibault Fiolet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts

(2019) Jean-Jacques Tudesq et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Aspergillus fumigatus and Aspergillosis in 2019

(2019) Jean-Paul Latgé et al.   CLINICAL MICROBIOLOGY REVIEWS

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum

(2017) Alexandre Alanio et al.   Frontiers in Microbiology

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?: Table 1.

(2016) Alexandre Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Macrolides, inflammation and the lung microbiome: untangling the web of causality

(2016) Robert P Dickson et al.   THORAX

ARDS

(2009) Quentin de Hemptinne et al.   CHEST

Trends in invasive fungal infections, with emphasis on invasive aspergillosis

(2009) Z. Erjavec et al.   CLINICAL MICROBIOLOGY AND INFECTION